Artificial Intelligence and Structured Data: Driving Process Efficiency for Medical Device Manufacturers
As more and more clinical trials are conducted internationally, with a higher level of protocol complexity, and with increased competition to get medical products to market faster globally, the need for efficient and streamlined clinical product development is greater than ever.
Many clinical teams have experienced delays or bottlenecks in their programs as a result of not getting accurate local-language documentation to sites quickly enough. With companies working to bring innovative therapies to market faster, the effective localization of clinical documentation has never been more critical for success and staying competitive in a constantly evolving landscape.
This webinar will bring together industry leaders to explore the critical role of centralized localization in accelerating clinical timelines for global studies. During this webinar, the expert speakers will discuss how centralizing localization of documentation for global studies with the aid of new technologies, including artificial intelligence (AI), can significantly accelerate clinical and product launch timelines.
In this webinar, they will also discuss practical ways of leveraging technology automation and AI to streamline the localization process, and how these innovative tools have transformed the way clinical documentation is created and managed, offering unprecedented speed, accuracy and scalability. Through real-world application and case studies, the attendees will discover how leading companies have leveraged these approaches to overcome some of the greatest challenges in clinical product development across multiple languages and regions.
One such case study will be a close examination of the clinical programs for vaccines and other treatments for COVID-19, and an analysis of the tactics used to meet unprecedented timelines in those studies that can bring similar time efficiencies to all programs.
Register for this webinar today to gain insights into actionable strategies to reduce clinical timelines on a global scale, and to gain great clarity on how a centralized approach to localization can drive efficiency, enhance compliance and ultimately help in clinical product development.
